";s:4:"text";s:4107:" This leads to adherence problems, which, in turn, as Antonelli et al (2003) noted, reduces the duration of use. New modes of ventilation such as AVAPS may have a place in helping to control OHS through the use of assured volume-targeted pressure support. Brandon Peters, MD, is a board-certified neurologist and sleep medicine specialist. Traditionally there have been two standard methods of delivering ventilator support:AVAPS is a hybrid of these two modes and aims to delivery a guaranteed tidal volume (Windisch et al, 2005).Evidence suggests that volume targeting can improve the control of nocturnal hypoventilation and result in a significant decrease in transcutaneous carbon dioxide (PtcCO2), a method of non-invasive monitoring carbon dioxide via a probe placed on the skin, with the effect of normalising PtcCO2 during sleep.
… The pressure level between the IPAP and the EPAP is known as pressure support; this can be adjusted to increase patients’ tidal volume, which enables more of the carbon dioxide to be expelled, with the aim of reducing PaCO2.There are risks with high pressures including pneumothorax, so patients should be closely monitored in the initial stages of therapy. Managing the various problems associated with obesity is complex – hypoventilation and hypercapnic respiratory failure are a major problem.Several studies have demonstrated that NIV using positive pressure can reduce carbon dioxide levels and reverse hypercapnic respiratory failure, as well as improving sleep-disordered breathing.
Without treatment it can lead to serious and even life-threatening health problems. These procedures in people who are overweight and have sleep apnea have increased risks. Carrillo et al (2012) found that patients who have OHS with hypercapnic respiratory failure could be treated using a similar bilevel NIV protocol to that used for patients with COPD; further to that, outcomes for patients with OHS were better than for those with COPD. In mild OSA, studies have shown that CPAP and bilevel non-invasive ventilation (NIV) can be equally effective at reducing daytime hypercapnia (Piper et al, 2008).Bilevel NIV in OHS can provide both the inspiratory pressure and expiratory pressure to enable patients to:Bilevel NIV has been shown to be effective in many studies of acute hypercapnic respiratory failure in chronic obstructive pulmonary disease (COPD) (Keenan et al, 2011). The dysfunctional breathing that characterizes the disease leads to an imbalance in the chemical levels of the blood. Obesity hypoventilation syndrome is a breathing disorder that affects some people who have been diagnosed with obesity. The treatment options for obesity hypoventilation syndrome (OHS) can be divided into tackling the two most important features of the disorder: weight loss and breathing support. It is helpful to have a sleep study called a Obesity hypoventilation syndrome affects physical and mental health.